Leslie Tari

CIK 1870270 · CHIEF SCIENTIFIC OFFICER · last filed 2025-03-13

Leslie Tari is a CHIEF SCIENTIFIC OFFICER who has filed 15 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider sold $38.9K of CDTX on Mar 13, 2025. Across all open-market trades the lifetime net is −$111.2K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

15

Lifetime Open-Market Net

-$111.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Cidara Therapeutics, Inc. (CDTX) Delisted CHIEF SCIENTIFIC OFFICER 16,288 $221.38 $3.61M -$111.2K 15 2025-03-13

Recent Filings

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-03-13 Cidara Therapeutics, Inc. (CDTX) Delisted Sell (S) −1,773 -$38.9K EDGAR
2024-10-02 Cidara Therapeutics, Inc. (CDTX) Delisted Grant (A) $0 EDGAR
2024-09-13 Cidara Therapeutics, Inc. (CDTX) Delisted Sell (S) −909 -$10.6K EDGAR
2024-03-20 Cidara Therapeutics, Inc. (CDTX) Delisted Grant (A) +111,250 $0 EDGAR
2024-03-12 Cidara Therapeutics, Inc. (CDTX) Delisted Sell (S) −21,029 -$14.1K EDGAR
2023-09-13 Cidara Therapeutics, Inc. (CDTX) Delisted Sell (S) −18,469 -$17.5K EDGAR
2023-08-14 Cidara Therapeutics, Inc. (CDTX) Delisted Buy (P) +10,000 $9.7K EDGAR
2023-03-29 Cidara Therapeutics, Inc. (CDTX) Delisted Grant (A) +90,000 $0 EDGAR
2023-03-13 Cidara Therapeutics, Inc. (CDTX) Delisted Sell (S) −7,562 -$11.6K EDGAR
2023-01-27 Cidara Therapeutics, Inc. (CDTX) Delisted Sell (S) −11,814 -$14.2K EDGAR
Showing 110 of 15
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.